NOS2 and metabolic syndrome: In conclusion, despite the insufficient effect of GYY-4137 on adiposity, dyslipidemia, and cardiac remodeling, the slow-releasing H2S donor triggered beneficial vasoactive effects: a decreased BP, partially improved MA relaxation and TA contraction, which was associated with restored NO signaling, and decreased expression of the iNOS and TNFα proteins.